UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): February 12, 2002
COMMISSION FILE NUMBER 333-92383
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(Exact Name of Registrant as specified in its Charter)
DELAWARE 06-1397316
(State of Incorporation) (I.R.S. Employer Identification No.)
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS 01887
(Address of Principal Executive Offices) (Zip Code)
978-658-6000
(Registrant's Telephone Number, Including Area Code)
ITEM 5. OTHER EVENTS
On February 12, 2002, the Registrant issued a press release announcing the
consideration to be paid by its wholly-owned subsidiary, Charles River
Laboratories, Inc., in its cash tender offer for any and all of its outstanding
13.5% Senior Subordinated notes due 2009. A copy of the press release is filed
with this Form 8-K as Exhibit 99.1.
EXHIBIT 99.1
Press Release dated February 12, 2002
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
we have duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Dated: February 14, 2002
BY: /s/ Dennis R. Shaughnessy
------------------------------------------
Dennis R. Shaughnessy, Sr. Vice President,
Corporate Development, General Counsel
and Secretary